An interventional study of 0.6 mm tread pitch implant and 0.1 mm tread pitch implant in Dental Implants, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-12-16.
Sponsored by University Hospital, Ghent · Not applicable, Interventional, and Treatment
Patients who need more than 2 dental implants will be treated by the same implant type (conical 4mm diameter IBT Southern implants) but with different thread pitch design (0,6mm en 1,0mm type). In a 3 year clinical follow up period, the bone remodelling on X-rays is registered around these implants. The role of the thread pitch design will be investigated.
University Hospital, Ghent is the lead sponsor of 665 studies on the registry; 156 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Device: 0.6 mm tread pitch implant
Device: 0.1 mm tread pitch implant
0.6 mm tread pitch implant will be used
0.1 mm tread pitch implant will be used
To document the outcome of bone remodeling around IBT implants
Time frame: 3 years after implantation
To clinically and radiographically document the placement of both IBT implant thread types in the same patient
Time frame: over 2 years
3. Outcome differences will be detected per implant center, per treated area in the mouth, per case of prosthetic rehabilitation
Time frame: over 2 years
This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Ghent